Gene therapy for malignant mesothelioma: current prospects and challenges.
about
Oncolytic virotherapy for human malignant mesothelioma: recent advancesLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesP2X7 targeting inhibits growth of human mesotheliomaMDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.CREB-induced inflammation is important for malignant mesothelioma growth.New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesotheliomaCombination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma.Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells.Impact of Different Promoters on Episomal Vectors Harbouring Characteristic Motifs of Matrix Attachment Regions.Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma.Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity.
P2860
Q26826590-785FF72F-E4F5-4052-BEF2-16A6161E31D5Q28395597-D4FDFD1E-CF17-4890-98AA-7DA8FF0F2158Q28468633-D6181951-33CA-43AB-BCD7-1CF71406EEAFQ31019143-93088CEA-585E-44FA-A86C-250200BA05D5Q34302855-BA54AD8E-2A4D-48D2-80AD-1E912FB2FBA4Q35042668-584C480F-E034-4F58-8ABE-5744562DE05AQ35176037-00C3CAE2-BE50-4E24-ACF2-B0712BF825F3Q36074154-18B1F1D6-479D-4D97-8F96-D93B8F15ECA3Q36544867-95D0B7FC-4192-4E60-BA4E-C9861DF23CC9Q36937744-74D81E48-7745-41D1-8E86-321A025CCABBQ37482664-587E39AC-F831-445B-96E5-C6FAA4365FCCQ39107708-30CD2290-4174-481C-951B-B2ACAC0FC8B3Q41279899-FE1899A6-67A0-422E-A779-449B937EFC8AQ55311618-F41055E2-C938-4FDF-B6E1-045FD4C54C50
P2860
Gene therapy for malignant mesothelioma: current prospects and challenges.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gene therapy for malignant mesothelioma: current prospects and challenges.
@en
type
label
Gene therapy for malignant mesothelioma: current prospects and challenges.
@en
prefLabel
Gene therapy for malignant mesothelioma: current prospects and challenges.
@en
P2093
P2860
P356
P1433
P1476
Gene therapy for malignant mesothelioma: current prospects and challenges.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2013.1
P577
2013-02-08T00:00:00Z